FDA Import Refusal 1FX-1775094-5/10002/1 — Cipla Ltd
The FDA refused shipment 1FX-1775094-5/10002/1 from Cipla Ltd (India) on Sep 22, 2026. The refused product falls under Drugs and Biologics — LEVOCETIRIZINE DIHYDROCHLORIDE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 22, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDA51 LEVOCETIRIZINE DIHYDROCHLORIDE
- Charges
- 75